XASX
SDV
Market cap58mUSD
Dec 05, Last price
0.46AUD
1D
1.10%
1Q
48.39%
Jan 2017
209.38%
IPO
-97.01%
Name
SciDev Ltd
Chart & Performance
P/E
40.20
P/S
0.80
EPS
0.01
Div Yield, %
—
Shrs. gr., 5y
20.19%
Rev. gr., 5y
106.28%
Revenues
109m
+21.59%
Net income
2m
P
CFO
6m
+34.61%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
SciDev Limited engages in supply of process control, professional services, equipment design and construction, and chemistry in Australia and the United States. The company offers coagulants and flocculants in powder and liquid form under the MaxiFlox and MaxiDry name; engineering and process control; chemistry products for applications, including thickening, filtration, centrifuging, friction reduction, shale inhibition, rheology control, and carrier fluids; chemical batching, storage, and dosage systems; engineering solutions and technologies under the TrueMud and OptiFlox name; friction reducers under the DrySlik, WetSlik, and CarrySlik names; and dynamic shears. It serves water and wastewater treatment, mining and minerals processing, oil and gas, construction, food processing, dairy, power generation, personal products and cosmetics manufacturing, paper and cardboard manufacturing, and paint manufacturing industries. The company was formerly known as Intec Limited and changed its name to SciDev Limited in March 2017. SciDev Limited was incorporated in 1973 and is headquartered in Kings Park, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||